 Is the reason why big pharma and the FDA haven't gotten involved just yet is because marijuana itself remains a Schedule 1 drug? Does that have anything to do with the lack of clinical studies into the effects of CBD? Yeah, that has everything to do with it. It's really difficult to study drugs that are Schedule 1 and there actually are pharmaceuticals that are developing drugs that use cannabinoids, not just CBD but THC and CBN and CBG. But we will definitely see more of them as it becomes better regulated. And the one pharmaceutical that has the drug that's been approved, they've done a lot of the studies and so I can't be totally mad at them because they have in some ways paved the way to say, this is a safe ingredient, like there were no, you know, negative side effects to the people who were in the trial and so that helps.